Tag Archives: ONCS

Friday’s Midday Stock Update: Navios Maritime Partners Lp (NMM), Cormedix Inc (CRMD), Acelrx (ACRX), OncoSec Medical (ONCS), CDTi Advanced Materials Inc (CDTI)

So far Friday, November 23, NASDAQ is up 0.81% and the S&P is up 0.83%. Here are this morning’s most active stocks: Navios Maritime Partners Lp (NMM – Research Report), Cormedix Inc (CRMD – Research Report), Acelrx (ACRX – Research

Analyst Explains Why They Downgraded Their Rating on OncoSec Medical (ONCS)

In a report released today, Ram Selvaraju from H.C. Wainwright downgraded OncoSec Medical (ONCS – Research Report) to Hold, with a price target of $1. The company’s shares closed yesterday at $0.87, close to its 52-week low of $0.68. Selvaraju

OncoSec Medical (ONCS) Gets a Buy Rating from Maxim Group

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on OncoSec Medical (ONCS – Research Report), with a price target of $5. The company’s shares opened today at $0.79, close to its 52-week low of

H.C. Wainwright Reiterates Their Buy Rating on OncoSec Medical (ONCS)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS) today and set a price target of $4. The company’s shares closed yesterday at $1.66. Selvaraju commented: “Our price target is derived from a market value

OncoSec Medical (ONCS) Gets a Buy Rating from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS), with a price target of $4. The company’s shares closed on Friday at $1.61. Selvaraju wrote: “Our price target is derived

OncoSec Medical (ONCS) Initiated with a Buy at H.C. Wainwright

OncoSec Medical (NASDAQ: ONCS) received a Buy rating and a $4 price target from H.C. Wainwright analyst Ram Selvaraju today. The company’s shares closed yesterday at $1.51. Selvaraju observed: “Our price target is derived from a market value of $222M